log in

Antibody Technology Research Group (ARG)
| Current Members | Studies | Membership History |

The Antibody-Technology Research Group is dedicated to:
    • Sharing it’s collective knowledge about generating, producing, purifying, fragmenting and conjugating antibodies amongst it’s members and within the larger scientific community
    • Providing a mechanism by which protocols, organizational structures and fiscal approaches could collected, shared and compared
    • Advancing and evaluating the technology within the antibody field (i.e. rabbit monoclonal antibodies, phage display technology)

Current Membership
Dr. Kathleen M Brundage - West Virginia University
Dr. Dan L Crimmins - Washington University School of Medicine
Ms. Linda G. Green - University of Florida
Mr. Gregory R. Halverson - New York Blood Center
Dr. John E Harlan - Abbott Laboratories
Dr Karen R Jonscher (EB liaison) - University of Colorado Denver
Dr Robert H Carnahan (Co-chair) - Vanderbilt University Medical Center
Dr. Frances Weis-Garcia (Co-chair) - Memorial Sloan Kettering Cancer Center
Studies
1) Love them or Hate them … Harnessing the power of antibodies is not always easy ... Antibodies are extremely powerful reagents in a scientist’s toolbox. To make it easier to create novel antibodies for and use existing antibodies in your unique experiments, the Antibody Technology Research Group is compiling a dynamic intellectual repository focused on antibodies technologies enabling all of us to address our own antibody challenges by continuously learning from each other. We invite you to spend 5 to 15 minutes sharing your knowledge from which the initial installment will be created. In return, you and your institutions will be cited for each contribution in the antibody repository and you will have access to it’s complied knowledge before it goes public. Submission topics include, but are by no means limited to: • Generating novel antibodies (immunization strategies, fusion protocols, screening strategies) • Producing and purifying antibodies • Labeling antibodies • Using antibodies (i.e. Flow Cytometry, Microscopy, ChIp-Seq, In vivo applications). To learn more, please review the attachment below which contains the complete announcement, people to contact and a sample PEG based somatic cell fusion protocol.
    - Love them or Hate them …
Membership History
Member Name Organization Details
Dr. Anthony T Yeung Fox Chase Cancer Ctr  EB Liaison: 04/10 - 04/11